Avilés A, Díaz N R, Neri N, Cleto S, Talavera A
Departament of Hematology, Oncology Hospital, National Medical Center, México.
Clin Lab Haematol. 2000 Aug;22(4):215-20. doi: 10.1046/j.1365-2257.2000.00307.x.
Angiocentric T cell/natural killer (NK) nasal lymphoma remains a rare clinical presentation in North America and Europe but is more common in Asia and Latin America. We have reviewed 108 cases of angiocentric T/NK cell lymphoma of the nasal cavity with a view to establishing prognostic factors. Most patients were high or high intermediate clinical risk and had additional poor prognostic factors such as bulky disease, high levels of beta 2 microglobulin, advanced stage and multiple extranodal involvement. At 8 years, overall survival was 82%, 90% and 84% for low-intermediate, high-intermediate and high clinical, respectively. Disease free survival was very similar: 79%, 83% and 80%, respectively. Multivariate analysis did not identify any factor influencing overall survival and disease-free survival. There was no evidence that the international prognostic index (IPI) was applicable in these patients and it appears that angiocentric T/NK cell lymphoma is an independent prognostic factor itself.
血管中心性T细胞/自然杀伤(NK)细胞性鼻腔淋巴瘤在北美和欧洲仍然是一种罕见的临床表现,但在亚洲和拉丁美洲更为常见。我们回顾了108例鼻腔血管中心性T/NK细胞淋巴瘤病例,旨在确定预后因素。大多数患者为高或高中度临床风险,并有其他不良预后因素,如肿块较大、β2微球蛋白水平高、晚期和多个结外受累。8年时,低中度、高中度和高临床风险患者的总生存率分别为82%、90%和84%。无病生存率非常相似,分别为79%、83%和80%。多变量分析未发现任何影响总生存率和无病生存率的因素。没有证据表明国际预后指数(IPI)适用于这些患者,血管中心性T/NK细胞淋巴瘤似乎本身就是一个独立的预后因素。